Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Circulating Biomarkers is Scopus-indexed (Q2, CiteScore 5.6), DOAJ. Published by AboutScience Srl.
Checked against the index lists dated .
ISSN 1849-4544Verify ISSN ↗
Publisher: AboutScience Srl
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry (medical) | 26 / 78 | 67th | Q2 |
| Clinical Biochemistry | 47 / 124 | 62nd | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q2, CiteScore 5.6.
Journal of Circulating Biomarkers is Q2 in Biochemistry (medical) (rank 26 of 78) and Q2 in Clinical Biochemistry (rank 47 of 124), by CiteScore 2025.
Journal of Circulating Biomarkers is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5.6, quartile Q2, 67th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.656, quartile Q2, with an H-index of 22.
The publisher lists an article processing charge of about US$1,617 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Circulating Biomarkers is published by AboutScience Srl. Its ISSN is 1849-4544.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Journal of Circulating Biomarkers has an h-index of 24 and a 2-year mean of 1.38 citations per paper (OpenAlex). Its Scopus CiteScore is 5.6, quartile Q2. On 2-year citations it ranks #40 of 77 Scopus journals in Biochemistry (medical).
Journal of Circulating Biomarkers published 9 papers in 2025; its busiest recent year was 2018 with 24. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 39 research articles (2021–2026), authors are most often from India (15.4%), United States (11.5%) and Germany (11.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.